TRAF1 and Its Biological Functions
10.1007/978-0-387-70630-6_2
Crossref book-chapter
Springer New York
Advances in Experimental Medicine and Biology (297)
Bibliography

Lee, S. Y., & Choi, Y. (n.d.). TRAF1 and Its Biological Functions. TNF Receptor Associated Factors (TRAFs), 25–31.

Authors 2
  1. Soo Young Lee (first)
  2. Yongwon Choi (additional)
References 46 Referenced 41
  1. Baker SJ, Reddy EP. Transducers of life and death: TNF receptor superfamily and associated proteins. Oncogene 1996; 12:1–9. / Oncogene by S.J. Baker (1996)
  2. Arch RH, Gedrich RW, Thompson CB. Tumor necrosis factor receptor-associated factors (TRAFs) — A family of adapter ptoteins that regulates life and death. Genes Dev 1998; 12:2821–2830. (10.1101/gad.12.18.2821) / Genes Dev by R.H. Arch (1998)
  3. Kaufman D, Choi Y. Signaling by tumor necrosis factor receptors: Pathways, paradigms and targets for therapeutic modulation. Intern Rev Immunol 1999; 18:405–427. (10.3109/08830189909088491) / Intern Rev Immunol by D. Kaufman (1999)
  4. Inoue J, Ishida T, Tsukamoto N et al. Tumor necrosis factor receptor-associated factor (TRAF) family: Adapter proteins that mediate cytokine signaling. Exp Cell Res 2000; 254:14–24. (10.1006/excr.1999.4733) / Exp Cell Res by J. Inoue (2000)
  5. Wajant H, Henkler F, Scheurich P. The TNF-receptor-associated factor family scaffold molecules for cytokine receptors, kinases and their regulators. Cell Signal 2001; 13:389–400. (10.1016/S0898-6568(01)00160-7) / Cell Signal by H. Wajant (2001)
  6. Chung JY, Park YC, Ye H et al. All TRAFs are not created equal: Common and distinct molecular mechanisms of TRAF-mediated signal transduction. J Cell Sci 2002; 115:679–688. (10.1242/jcs.115.4.679) / J Cell Sci by J.Y. Chung (2002)
  7. Locksley RM, Killeen N, Lenardo MJ. The TNF and TNF receptor superfamilies: Integrating mammalian biology. Cell 2001; 104:487–501. (10.1016/S0092-8674(01)00237-9) / Cell by R.M. Locksley (2001)
  8. Yeh WC, Shahinian A, Speiser D et al. Early lethality, functional NF-κB activation, and increased sensitivity to TNF-induced cell death in TRAF2-deficient mice. Immunity 1997; 7:715–725. (10.1016/S1074-7613(00)80391-X) / Immunity by W.C. Yeh (1997)
  9. Tada K, Okazaki T, Sakon S et al. Critical roles of TRAF2 and TRAF5 in tumor necrosis factor-induced NF-κB activation and protection from cell death. J Biol Chem 2001; 276:36530–36534. (10.1074/jbc.M104837200) / J Biol Chem by K. Tada (2001)
  10. Lomaga MA, Yeh WC, Sarosi I et al. TRAF6 deficiency results in osteopetrosis and defective interleukin-1, CD40, and LPS signaling. Genes Dev 1999; 13:1015–1024. (10.1101/gad.13.8.1015) / Genes Dev by M.A. Lomaga (1999)
  11. Dempsey PW, Doyle SE, He JQ et al. The signaling adaptors and pathways activated by TNF superfamily. Cytokine Growth Factor Rev 2003; 14:193–209. (10.1016/S1359-6101(03)00021-2) / Cytokine Growth Factor Rev by P.W. Dempsey (2003)
  12. Wajant H, Pfizenmaier K, Scheurich P. Tumor necrosis factor signaling. Cell Death Differ 2003; 10:45–65. (10.1038/sj.cdd.4401189) / Cell Death Differ by H. Wajant (2003)
  13. Rothe M, Wong SC, Henzel WJ et al. A novel family of putative signal transducers associated with the cytoplasmic domain of the 75 kDa tumor necrosis factor receptor. Cell 1994; 78:681–692. (10.1016/0092-8674(94)90532-0) / Cell by M. Rothe (1994)
  14. Mosialos G, Birkenbach M, Yalamanchili R et al. The Epstein-Barr virus transforming protein LMP1 engages signaling proteins for the tumor necrosis factor receptor family. Cell 1995; 80:389–399. (10.1016/0092-8674(95)90489-1) / Cell by G. Mosialos (1995)
  15. Lee SY, Park CG, Choi Y. T cell receptor-dependent cell death of T cell hybridomas mediated by the CD30 cytoplasmic domain in association with tumor necrosis factor receptor-associated factors. J Exp Med 1996; 183:669–674. (10.1084/jem.183.2.669) / J Exp Med by S.Y. Lee (1996)
  16. Hsu H, Shu HB, Pan MG et al. TRADD-TRAF2 and TRADD-FADD interactions define two distinct TNF receptor 1 signal transduction pathways. Cell 1996; 84:299–308. (10.1016/S0092-8674(00)80984-8) / Cell by H. Hsu (1996)
  17. Natoli G, Costanzo A, Ianni A et al. Activation of SAPK/JNK by TNF receptor 1 through a noncytotoxic TRAF2-dependent pathway. Science 1997; 275:200–203. (10.1126/science.275.5297.200) / Science by G. Natoli (1997)
  18. Zapata JM, Krajewska M, Krajewski S et al. TNFR-associated factor family protein expression in normal tissues and lymphoid malignancies. J Immunol 2000; 165:5084–5096. (10.4049/jimmunol.165.9.5084) / J Immunol by J.M. Zapata (2000)
  19. Schwenzer R, Siemienski K, Liptay S et al. The human tumor necrosis factor (TNF) receptor-associated factor 1 gene (TRAF1) is up-regulated by cytokines of the TNF ligand family and modulates TNF-induced activation of NF-κB and c-Jun N-terminal kinase. J Biol Chem 1999; 274:19368–19374. (10.1074/jbc.274.27.19368) / J Biol Chem by R. Schwenzer (1999)
  20. Durkop H, Foss HD, Demel G et al. Tumor necrosis factor receptor-associated factor 1 is overexpressed in Reed-Sternberg cells of Hodgkin’s disease and Epstein-Barr virus-transformed lymphoid cells. Blood 1999; 93:617–623. (10.1182/blood.V93.2.617) / Blood by H. Durkop (1999)
  21. Dunn IF, Geha RS, Tsitsikov EN. Structure of the murine TRAF1 gene. Mol Immunol 1999; 36:611–617. (10.1016/S0161-5890(99)00075-9) / Mol Immunol by I.F. Dunn (1999)
  22. Wang X, Wang Q, Hu W et al. Regulation of phorbol ester-mediated TRAF1 induction in human colon cancer cells through a PKC/RAF/ERK/NF-κB-dependent pathway. Oncogene 2004; 23:1885–1195. (10.1038/sj.onc.1207312) / Oncogene by X. Wang (2004)
  23. Zapata JM, Reed JC. TRAF1: Lord without a RING. Sci STKE 2002; 21:PE27. / Sci STKE by J.M. Zapata (2002)
  24. Hsu H, Xiong J, Goeddel DV. The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation. Cell 1995; 81:495–504. (10.1016/0092-8674(95)90070-5) / Cell by H. Hsu (1995)
  25. Ye H, Park YC, Kreishman M et al. The structural basis for the recognition of diverse receptor sequences by TRAF2. Mol Cell 1999; 4:321–330. (10.1016/S1097-2765(00)80334-2) / Mol Cell by H. Ye (1999)
  26. Park YC, Burkitt V, Villa AR et al. Structural basis for self-association and receptor recognition of human TRAF2. Nature 1999; 398:533–538. (10.1038/19110) / Nature by Y.C. Park (1999)
  27. Ye H, Arron JR, Lamothe B et al. Distinct molecular mechanism for initiating TRAF6 signalling. Nature 2002; 418:443–447. (10.1038/nature00888) / Nature by H. Ye (2002)
  28. Gedrich RW, Gilfillan MC, Duckett CS et al. CD30 contains two binding sites with different specificities for members of the tumor necrosis factor receptor-associated factor family of signal transducing proteins. J Biol Chem 1996; 271:12852–12858. (10.1074/jbc.271.22.12852) / J Biol Chem by R.W. Gedrich (1996)
  29. Lee SY, Lee SY, Kandala G et al. CD30/TNF receptor-associated factor interaction: NF-κB activation and binding specificity. Proc Natl Acad Sci USA 1996; 93:9699–9703. (10.1073/pnas.93.18.9699) / Proc Natl Acad Sci USA by S.Y. Lee (1996)
  30. Duckett CS, Gedrich RW, Gilfillan MC et al. Induction of nuclear factor κB by the CD30 receptor is mediated by TRAF1 and TRAF2. Mol Cell Biol 1997; 17:1535–1542. (10.1128/MCB.17.3.1535) / Mol Cell Biol by C.S. Duckett (1997)
  31. Carpentier I, Beyaert R. TRAF1 is a TNF inducible regulator of NF-κB activation. FEBS Lett 1999; 460:246–250. (10.1016/S0014-5793(99)01356-3) / FEBS Lett by I. Carpentier (1999)
  32. Arron JR, Pewzner-Jung Y, Walsh MC et al. Regulation of the subcellular localization of tumor necrosis factor receptor-associated factor (TRAF)2 by TRAF1 reveals mechanisms of TRAF2 signaling. J Exp Med 2002; 196:923–934. (10.1084/jem.20020774) / J Exp Med by J.R. Arron (2002)
  33. Fotin-Mleczek M, Henkler F, Hausser A et al. Tumor necrosis factor receptor-associated factor (TRAF) 1 regulates CD40-induced TRAF2-mediated NF-κB activation. J Biol Chem 2004; 279:677–685. (10.1074/jbc.M310969200) / J Biol Chem by M. Fotin-Mleczek (2004)
  34. Chen G, Goeddel DV. TNF-R1 signaling: A beautiful pathway. Science 2002; 296:1634–1635. (10.1126/science.1071924) / Science by G. Chen (2002)
  35. Karin M, Lin A. NF-κB at the crossroads of life and death. Nat Immunol 2002; 3:221–227. (10.1038/ni0302-221) / Nat Immunol by M. Karin (2002)
  36. Shu HB, Takeuchi M, Goeddel DV. The tumor necrosis factor receptor 2 signal transducers TRAF2 and c-IAP1 are components of the tumor necrosis factor receptor 1 signaling complex. Proc Natl Acad Sci USA 1996; 93:13973–13978. (10.1073/pnas.93.24.13973) / Proc Natl Acad Sci USA by H.B. Shu (1996)
  37. Wang CY, Mayo MW, Korneluk RG et al. NF-κB antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation. Science 1998; 281:1680–1683. (10.1126/science.281.5383.1680) / Science by C.Y. Wang (1998)
  38. Speiser DE, Lee SY, Wong B et al. A regulatory role for TRAF1 in antigen-induced apoptosis of T cells. J Exp Med 1997; 185:1777–1783. (10.1084/jem.185.10.1777) / J Exp Med by D.E. Speiser (1997)
  39. Irmler M, Steiner V, Ruegg C et al. Caspase-induced inactivation of the anti-apoptotic TRAF1 during Fas ligand-mediated apoptosis. FEBS Lett 2000; 468:129–133. (10.1016/S0014-5793(00)01206-0) / FEBS Lett by M. Irmler (2000)
  40. Jang HD, Chung YM, Baik JH et al. Caspase-cleaved TRAF1 negatively regulates the antiapoptotic signals of TRAF2 during TNF-induced cell death. Biochem Biophys Res Commun 2001; 281:499–505. (10.1006/bbrc.2001.4369) / Biochem Biophys Res Commun by H.D. Jang (2001)
  41. Leo E, Deveraux QL, Buchholtz C et al. TRAF1 is a substrate of caspases activated during tumor necrosis factor receptor-alpha-induced apoptosis. J Biol Chem 2001; 276:8087–8093. (10.1074/jbc.M009450200) / J Biol Chem by E. Leo (2001)
  42. Henkler F, Baumann B, Fotin-Mleczek M et al. Caspase-mediated cleavage converts the tumor necrosis factor (TNF) receptor-associated factor (TRAF)-1 from a selective modulator of TNF receptor signaling to a general inhibitor of NF-κB activation. J Biol Chem 2003; 278:29216–29230. (10.1074/jbc.M211090200) / J Biol Chem by F. Henkler (2003)
  43. Tsitsikov EN, Laouini D, Dunn IF et al. TRAF1 is a negative regulator of TNF signaling: Enhanced TNF signaling in TRAF1-deficient mice. Immunity 2001; 15:647–657. (10.1016/S1074-7613(01)00207-2) / Immunity by E.N. Tsitsikov (2001)
  44. Nakano H, Sakon S, Koseki H et al. Targeted disruption of Traf5 gene causes defects in CD40-and CD27-mediated lymphocyte activation. Proc Natl Acad Sci USA 1999; 96:9803–9808. (10.1073/pnas.96.17.9803) / Proc Natl Acad Sci USA by H. Nakano (1999)
  45. Xu Y, Cheng G, Baltimore D. Targeted disruption of TRAF3 leads to postnatal lethality and defective T-dependent immune responses. Immunity 1996; 5:407–415. (10.1016/S1074-7613(00)80497-5) / Immunity by Y. Xu (1996)
  46. Regnier CH, Masson R, Kedinger V et al. Impaired neural tube closure, axial skeleton malformations, and tracheal ring disruption in TRAF4-deficient mice. Proc Natl Acad Sci USA 2002; 99:5585–5590. (10.1073/pnas.052124799) / Proc Natl Acad Sci USA by C.H. Regnier (2002)
Dates
Type When
Created 17 years, 8 months ago (Dec. 14, 2007, 12:02 p.m.)
Deposited 3 years, 11 months ago (Aug. 30, 2021, 9:21 a.m.)
Indexed 5 months ago (March 27, 2025, 4:19 a.m.)
Funders 0

None

@inbook{Lee, title={TRAF1 and Its Biological Functions}, ISBN={9780387706306}, url={http://dx.doi.org/10.1007/978-0-387-70630-6_2}, DOI={10.1007/978-0-387-70630-6_2}, booktitle={TNF Receptor Associated Factors (TRAFs)}, publisher={Springer New York}, author={Lee, Soo Young and Choi, Yongwon}, pages={25–31} }